e-Drug3D

2185

MILSAPERIDONE

INN
MILSAPERIDONE

cas 501373-88-2

CLASS

NERVOUS SYSTEM
ANTIPSYCHOTIC
BIPOLAR I DISORDER
DOPAMINE TYPE 2 (D2) AND SEROTONIN TYPE 2 (5-HT2) ANTAGONISM

ROUTE (list)

ORAL

ATC code

PK parameters

Tmax 4 HOUR
VD 2029 LITER
Cl 50.5 LITER / HOUR
PPB 92 PERCENT
t1/2 26 HOUR

Target

TARGET DOPAMINE TYPE 2 RECEPTOR
SEROTONIN TYPE 2 (5-HT2) RECEPTOR

Download SDF file

Benzenemethanol, 4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxy-alpha-methyl-, (alphaS)-

Formula:
C24H29FN2O4

Calculated chemical properties:

MW 428.49
NB_atoms 31
XLogP 4.68
PSA 71.824
NB_HD 1
NB_HA 6
fsp3 0.46
Lipinski(0=no;1=yes) 1

FDA
NDA 220358 (label) INN (MILSAPERIDONE) BYSANTI (VANDA PHARMS INC) APPROVAL= AP YEAR= 2026 NEWMOLECULARENTITY